Junfeng Zhang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Signaling Pathway

High Throughput

Top Venues

Journal of translational medicine

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Junfeng Zhang, Fuzhong Liu, Wenjia Guo, Xing Bi, Shuai Yuan, Fuerhaiti Shayiti, Ting Pan, Kailing Li, Peng Chen
Single-cell transcriptome sequencing reveals aberrantly activated inter-tumor cell signaling pathways in the development of clear cell renal cell carcinoma. Journal of translational medicine 22 (1) (2024)
Junfeng Zhang, Fuzhong Liu, Wenjia Guo, Xing Bi, Shuai Yuan, Fuerhaiti Shayiti, Ting Pan, Kailing Li, Peng Chen
Single-cell transcriptome sequencing reveals aberrantly activated inter-tumor cell signaling pathways in the development of clear cell renal cell carcinoma. Journal of translational medicine 22 (1) (2024)
Junfeng Zhang, Fuzhong Liu, Wenjia Guo, Xing Bi, Shuai Yuan, Fuerhaiti Shayiti, Ting Pan, Kailing Li, Peng Chen
Single-cell transcriptome sequencing reveals aberrantly activated inter-tumor cell signaling pathways in the development of clear cell renal cell carcinoma. Journal of translational medicine 22 (1) (2024)
Junfeng Zhang, Fuzhong Liu, Wenjia Guo, Xing Bi, Shuai Yuan, Fuerhaiti Shayiti, Ting Pan, Kailing Li, Peng Chen
Single-cell transcriptome sequencing reveals aberrantly activated inter-tumor cell signaling pathways in the development of clear cell renal cell carcinoma. Journal of translational medicine 22 (1) (2024)
Wei Peng, Huan Feng, Linhao Pang, Junfeng Zhang, Yi Hao, Xian Wei, Qi-Dong Xia, Zhewen Wei, Wen Song, Shao-Gang Wang, Ji-Hong Liu, Ke Chen, Tao Wang
Downregulation of CAMK2N1 due to DNA Hypermethylation Mediated by DNMT1 that Promotes the Progression of Prostate Cancer. Journal of oncology 2023 (2023)
Wei Peng, Huan Feng, Linhao Pang, Junfeng Zhang, Yi Hao, Xian Wei, Qi-Dong Xia, Zhewen Wei, Wen Song, Shao-Gang Wang, Ji-Hong Liu, Ke Chen, Tao Wang
Downregulation of CAMK2N1 due to DNA Hypermethylation Mediated by DNMT1 that Promotes the Progression of Prostate Cancer. Journal of oncology 2023 (2023)